Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

Non-transfusion-dependent thalassemia encompasses three clinically distinct forms -- beta-thalassaemia intermedia, hemoglobin ...

DelveInsight's report on Alpha Thalassemia provides a comprehensive analysis of the epidemiology and <a target=_blank href= ...

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...

On January 21st, the Thalassemia International Federation (TIF) and BGI Genomics jointly hosted an educational webinar focused on thalassemia prevention in high-prevalence regions. Experts emphasized ...

To commemorate the 76th Republic Day, the Sardar Vallabhbhai Patel National Police Academy (SVPNPA), in partnership with the ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Everything you need to know about agonising sickle cell disease and the ‘revolutionary’ new DNA therapy that's being rolled ...

Thalassemia & Sickle Cell Society (TSCS) recently participated in the National Conference organized by the Federation of ...

For a school going child with thalassemia juggling the stress of monthly checkpoints with the hassle of monthly transfusions, the possibility of a permanent cure for the chronic condition is a ray of ...

The UK has approximately 17,500 individuals living with sickle cell disease, a condition particularly prevalent amongst those ...